ReviewFrontiers in cell and developmental biology2021

p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors.

Emanuela Grassilli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.